Print Page | Contact Us | Report Abuse | Sign In | Register
News & Press: EFAS - News


Friday 29 March 2019   (0 Comments)
Posted by: EFAS Secretariat
Share |
1.    As the past EFAS president, what are your impressions of the last two years?

On my years of presidency, I experienced the evolution of our Society. EFAS has been growing and growing and has now more members than fellow societies such as AOFAS and the FLAMECIP! This growth has also been perceived in the increasing number of participants in our EFAS basic and advanced courses, symposium and congress. We welcomed many young orthopaedic surgeons, who are always enthusiastic for expanding their scientific knowledge in our courses.

EFAS is at the core of this evolution, and I was happy to be involved in it. I thoroughly enjoyed coordinating the scientific teaching, organising medical exchanges and fellowships, contributing to the political lobbying, managing the administrative tasks with a new and impressive secretariat...

And last but not least, I valued the great friendship created between the members of EFAS, with minor exceptions, and the desire of people to participate in the great development of the foot and ankle surgery. 


2.    What is your best memory of your presidency?

One of the best moments of my presidency was at the 12th EFAS International Congress, which took place early October 2018 in Geneva. At this congress, EFAS did not only meet all our expectations, but it largely broke all records in terms of attendee numbers (800), quality of speakers, number of sponsors, and surpassed all financial expectations.

Another achievement needed to be mentioned is related to the collaboration with my EFAS Council colleagues and with the MCI’s staff members, whose importance and competence tremendously grew during these two years. 


3.    How do you see the future for EFAS?

EFAS has a bright future ahead, our society is becoming more and more important for the foot and ankle surgeon’s community and the whole industry around. Furthermore, the European Eucomed and Medtech regulations will give us more responsibilities and our industry sponsorship interest will increase again.

I also believe there will be a continuity in the development of:

  • EFAS Certificate
  • EFAS Score: validation and publication of EFAS Score in all member languages
  • EFAS Research Foundation: including expert group for evaluation of projects from industrial partners
  • Total Ankle Joint Replacement Registry: European wide registry with inclusion of existing national registries
  •  Increasing number of Specimen Lab Courses to 4 per year
  • Possible EFAS supervision for smaller societies and various groups of F&A surgeons and F&A technics